Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Liabilities: 2024-2025

Historic Other Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 1 years, with Sep 2025 value amounting to $5.2 million.

  • Eton Pharmaceuticals' Other Non-Current Liabilities was N/A to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is N/A change from last year.
  • Eton Pharmaceuticals' Other Non-Current Liabilities amounted to $5.2 million in Q3 2025, which was down 25.34% from $6.9 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Other Non-Current Liabilities registered a high of $6.9 million during Q2 2025, and its lowest value of $1.8 million during Q4 2024.
  • For the 2-year period, Eton Pharmaceuticals' Other Non-Current Liabilities averaged around $4.5 million, with its median value being $4.7 million (2025).